SynthesisEuropean journal of clinical pharmacology2024

The safety and efficacy of bevacizumab in treatment of recurrent low-grade glioma: a systematic review and meta-analysis.

Mohammad Amin Habibi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.